Low serum levels of 25-hydroxyvitamin D in severe preeclampsia: The need for early supplementation

Abstract

The purpose of this study was to analyze serum 25-hydroxyvitamin D levels in normal pregnant women, severe preeclampsia, and severe preeclampsia with complications. This research was a cross-sectional study; the sample was 86 third-trimester pregnant women consisting of 44 normal pregnant mothers, 30 severe preeclampsia and 12 people severe preeclampsia with complications. The diagnosis based on obstetrics and gynecology physicians who served at the research hospital. Serum levels of 25-hydroxyvitamin D are measured using VD (vitamin D) human Enzyme-Linked Immunosorbent Assay (ELISA) Kit. Serum levels of 25-hydroxyvitamin D showed that there were statistically significant differences in the normal pregnancy group, severe preeclampsia group, and severe preeclampsia group with complications. Low serum 25-hydroxyvitamin D levels were severe in severe preeclampsia, while the highest 25-hydroxyvitamin D serum levels were in complicated severe preeclampsia. Observation on medical records that the majority of severe preeclampsia has received treatment that increases serum levels 25-hydroxyvitamin D. Our study found that serum 25-hydroxyvitamin D levels will decrease as preeclampsia worsens and will increase again after receiving treatment. Earlier treatment in the early period of preeclampsia will be better than if there had been severe preeclampsia.